We are live on ! Find out more
PSTV

Plus Therapeutics
PSTV

Delisted

PSTV was delisted on the 31st of July, 2026.

Back to rankings

5 hedge funds and large institutions have $15.1M invested in Plus Therapeutics in 2015 Q2 according to their latest regulatory filings, with 3 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

217% more call options, than puts

Call options by funds: $19K | Put options by funds: $6K

200% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 1

67% more funds holding

Funds holding: 3 → 5 (+2)

22% less capital invested

Capital invested by funds: $19.3M → $15.1M (-$4.22M)

Holders
5
Holders Change
+2
Holders Change %
+66.67%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
–
Closed
1
Calls
$19K
Puts
$6K
Net Calls
+$13K
Net Calls Change
+$34K

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$4.58M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$4.58M
3
GC
Globeflex Capital
California
+$2.29M

Top Sellers

Rank Fund Capital Flow
1
BFA
BlackRock Fund Advisors
California
-$2.65M
2
BIM
BlackRock Investment Management
Delaware
-$329K
3
California State Teachers Retirement System (CalSTRS)
California State Teachers Retirement System (CalSTRS)
California
-$201K
4
TA
Teachers Advisors
New York
-$170K
5
RhumbLine Advisers
RhumbLine Advisers
Massachusetts
-$103K
Name Holding Trade Value Shares
Change 		Change in
Stake
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$3.79M +$4.58M +2 New
SM
2
Sabby Management
Florida
$2.99M +$4.58M +2 New
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.57M – – –
BIT
4
BlackRock Institutional Trust
California
$1.53M – – –
GC
5
Globeflex Capital
California
$894K +$2.29M +1 New
PCM
6
Perkins Capital Management
Minnesota
$615K – – –
TCIM
7
TIAA CREF Investment Management
New York
$502K – – –
Northern Trust
8
Northern Trust
Illinois
$418K – – –
Geode Capital Management
9
Geode Capital Management
Massachusetts
$390K – – –
Millennium Management
10
Millennium Management
New York
$379K – – –
PCMI
11
Princeton Capital Management Inc
New Jersey
$284K – – –
MCM
12
Marathon Capital Management
Maryland
$170K – – –
Goldman Sachs
13
Goldman Sachs
New York
$168K – – –
COPPSERS
14
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$117K – – –
PP
15
Paloma Partners
Connecticut
$96K – – –
RAM
16
Redmond Asset Management
Virginia
$96K – – –
CS
17
Credit Suisse
Switzerland
$75K – – –
Adage Capital Partners
18
Adage Capital Partners
Massachusetts
$70K – – –
Morgan Stanley
19
Morgan Stanley
New York
$70K – – –
Royal Bank of Canada
20
Royal Bank of Canada
Ontario, Canada
$64K – – –
Bank of New York Mellon
21
Bank of New York Mellon
New York
$61K – – –
CB
22
Commerce Bank
Missouri
$56K – – –
California Public Employees Retirement System
23
California Public Employees Retirement System
California
$55K – – –
Jacobs Levy Equity Management
24
Jacobs Levy Equity Management
New Jersey
$55K – – –
New York State Common Retirement Fund
25
New York State Common Retirement Fund
New York
$47K – – –
1
2 3 4

PSTV Hedge Fund Activity: Q2 2015 in Review

5 of the 3,713 institutional investors tracked by Wall St. Rank reported a position in Plus Therapeutics (PSTV) for Q2 2015, worth a combined $15.1M — down 22% from $19.3M a quarter earlier.

Buyers outnumbered sellers: 3 funds opened new PSTV positions and 1 closed out — a net gain of 2 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Sabby Management, opening a new position worth an estimated $4.58M. The largest seller was BlackRock Fund Advisors, exiting entirely with an estimated $2.65M sold.

  • 5 institutional investors held Plus Therapeutics (PSTV) as of Q2 2015, up from 3 in Q1 2015.
  • Funds reported $15.1M of Plus Therapeutics stock for Q2 2015, down 22% quarter-over-quarter.
  • 3 funds opened new Plus Therapeutics positions in Q2 2015 and 1 closed out, a net change of +2 holders.
  • The largest Plus Therapeutics buyer in Q2 2015 was Sabby Management, an estimated $4.58M added.
  • The largest Plus Therapeutics seller in Q2 2015 was BlackRock Fund Advisors, an estimated $2.65M sold.

Based on aggregated 13F filings for Q2 2015.